YorNight
- News and events
- Events
- YorNight
- YorNight 2015
- Activities and Events
- York Medical Society
- Incentivising the Pharma Industry To Develop Drugs That Do More Good Than Harm
Incentivising The Pharma Industry to Develop Drugs that Do More Good than Harm
Mark Sculpher
25 September 2015
8.10pm-8.30pmYork Medical Society (map)
FREE admission
No booking requiredWheelchair accessible
(through garden)
Event details
Pharmaceutical companies produce an array of new products each year, and health systems around the world have to decide which ones offer sufficient benefits to justify the use of highly constrained resources. In some clinical areas – notably cancer – there is evidence that the NHS fails to gain value for money from the numerous new drugs launched each year; indeed, many products do more harm than good to the population’s health. In contrast, the NHS is crying out for new antibiotics, but few are being developed. Why does this mismatch occur, and how can the NHS set the right incentives to the pharma industry to generate value for money products in high priority clinical areas?
